William H Rastetter Neurocrine Biosciences Inc (NBIX) insider trading activity

William H Rastetter is Director of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 40,360 shares of NBIX, which is worth approximately $5.17 Million. The most recent transaction as insider was on May 22, 2025, when has been sold 2,869 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.4K

7.65% 3M change

22.0% 12M change

Total Value Held $5.17 Million

WILLIAM H RASTETTER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 22 2025	BUY Exercise of conversion of derivative security	-	2,869 Added 6.64%	40,360 Common Stock
May 05 2025	SELL Open market or private sale	$3,306,000 $110.2 p/Share	30,000 Reduced 44.45%	37,491 Common Stock
May 05 2025	BUY Exercise of conversion of derivative security	$1,282,800 $42.76 p/Share	30,000 Added 30.77%	67,491 Common Stock
Aug 15 2024	SELL Open market or private sale	$2,090,332 $146.69 p/Share	14,250 Reduced 27.54%	37,491 Common Stock
Jan 02 2024	SELL Open market or private sale	$1,451,954 $131.47 p/Share	11,044 Reduced 17.59%	51,741 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$259,600 $12.98 p/Share	20,000 Added 24.16%	62,785 Common Stock
May 01 2023	SELL Open market or private sale	$436,149 $101.43 p/Share	4,300 Reduced 9.13%	42,785 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	$96,913 $12.71 p/Share	7,625 Added 13.94%	47,085 Common Stock
Apr 21 2023	SELL Open market or private sale	$633,811 $105.04 p/Share	6,034 Reduced 13.26%	39,460 Common Stock
Apr 21 2023	BUY Exercise of conversion of derivative security	$136,823 $12.71 p/Share	10,765 Added 19.13%	45,494 Common Stock
Apr 19 2023	SELL Open market or private sale	$94,815 $105.0 p/Share	903 Reduced 2.53%	34,729 Common Stock
Apr 19 2023	BUY Exercise of conversion of derivative security	$20,463 $12.71 p/Share	1,610 Added 4.32%	35,632 Common Stock
Apr 01 2022	SELL Open market or private sale	$1,018,409 $94.93 p/Share	10,728 Reduced 23.97%	34,022 Common Stock
Apr 01 2022	BUY Exercise of conversion of derivative security	$133,200 $6.66 p/Share	20,000 Added 30.89%	44,750 Common Stock

Also insider at

FATE

FATE THERAPEUTICS INC Healthcare

RGLS

Regulus Therapeutics Inc. Healthcare

DARE

Dare Bioscience, Inc. Healthcare

Director

WHR